Elon Musk’s Neuralink has secured $600 million in new funding, driving its valuation to $9 billion pre-money, according to recent reports. Although the identities of the investors involved in this latest round have not been disclosed, Neuralink’s swift valuation rise underscores growing investor confidence. Previously, the brain implant firm raised $43 million in venture capital in November 2023, when the company was valued at approximately $5 billion.
Earlier reporting this year indicated that Neuralink was targeting a $500 million raise at an $8.5 billion valuation, making this recent financing slightly larger than initially anticipated. The startup, founded by Musk, is developing advanced neural implants aimed at human-computer interaction. In a significant milestone last year, Neuralink received “breakthrough device” designation from the U.S. Food and Drug Administration (FDA).
To date, three individuals have undergone Neuralink implant procedures. Recently, a patient who is nonverbal showcased the technology’s potential by releasing a video demonstrating how he could edit and narrate YouTube content using only neural signals from his implant.
Neuralink has yet to publicly comment on the latest funding news.
